Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
NGS
Programmable depletion with CRISPR–Cas9: what DASH is, why it works, and where to use it.
December 2, 2025 -
4 min read
NGS
Variant calling through bulk RNA-seq is growing up: implications for oncology introduction.
December 1, 2025 -
3 min read
NGS
Next GeneSiS: cfDNA sequencing outperforms blood culture in sepsis.
December 1, 2025 -
4 min read
NGS
Understanding hybrid capture and the role of universal blockers.
December 1, 2025 -
6 min read
NGS
Challenges in synthetic oligonucleotide production: implications for NGS adapters introduction to NGS adapter synthesis.
December 1, 2025 -
3 min read
NGS
Optimal selection of read depth and length for bulk RNA-Seq: an updated perspective.
November 17, 2025 -
3 min read
NGS
Blurring the line: lncRNAs as hidden encoders of micropeptides.
October 17, 2025 -
5 min read
NGS
Circular RNAs as stable age and experience markers: new insights from Drosophila.
October 16, 2025 -
2 min read
